Exactly... we don't know the full extent of the business activities. Wouldn't it be prudent for minor shareholders to have a representative on the inside keeping an eye on what is going on?
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%